Aethoxysklerol solution for injection 30 mg ml ampoules 2 ml 5 pcs
Condition: New product
994 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Lauromacrogol 400
Release form
Solution
Composition
Active ingredient: Polidocanol Active ingredient concentration (mg): 30
Pharmacological effect
Sclerosing agent, non-ionic surfactant.
Pharmacokinetics
Distribution volume - 24.5 l, plasma protein binding - 64%, T1 / 2 - 4 h. Total Cl - 11.7 l / h, renal - 2.43 l / h, biliary - 3.14 l / h . With repeated injections does not accumulate.
Indications
For sclerosis of varicose veins of the limbs, esophagus, stomach, as well as hemorrhoids, peripheral and central veins telangiectasias.
Contraindications
Shock, endocarditis, myocarditis, chronic heart failure in the decompensation stage, acute infectious and inflammatory diseases accompanied by fever (including local), bronchial asthma, pulmonary diseases in the acute phase; diabetes mellitus in the phase of decompensation, diabetic microangiopathy; I trimester and after 36 weeks of pregnancy, with the exception of acute bleeding; hypersensitivity to the active substance. For sclerosis of varicose veins of the lower extremities: acute thrombosis of the superficial and deep veins, thrombophlebitis of the deep veins, occlusion of arteries of the 3rd and 4th degree. Not used in bedridden patients.
Precautionary measures
You can not enter in / a. When used in the ankle and ankle area, small amounts of 0.5% solution are recommended.
Use during pregnancy and lactation
It is contraindicated for use in the first trimester and after 36 weeks of pregnancy (with the exception of acute bleeding).
Dosage and administration
Individual, depending on indications and the applied dosage form.
Side effects
Systemic reactions: fever, exudative pleurisy are possible; rarely, skin rash; very rarely - collapse, dizziness, difficulty breathing and chest tightness, nausea, visual disturbances, local sensitivity disorders, metallic taste, anaphylactic shock. Local reactions: depending on the injection site, esophageal necrosis and ulceration may develop, dysphagia, esophageal stenosis, very rarely - esophageal perforation; hyperpigmentation, periphlebitis, thrombophlebitis, tissue necrosis (especially with paravasal administration); with sclerosis of hemorrhoids, transient pains are possible during and after the injection, very rarely, pain in the prostate gland, as well as transient erection disorders.
Interaction with other drugs
Enhances the arrhythmogenic effect of general anesthetics.
special instructions
Do not allow in / a introduction. The introduction of sclerosing agents into the veins of the facial part of the skull is possible only under strict indications. With extreme caution, it is used for varicose veins of the lower extremities in occlusion of arteries of the 2nd degree, as well as in elderly patients with limited ability to move and severe general condition. use with drugs for anesthesia there is a risk of arrhythmogenic action.